Leritrelvir Shows Enhanced Activity Against Drug-Resistant SARS-CoV-2 Variants, Study Finds
A new study demonstrates that leritrelvir, an antiviral drug approved in China, maintains stronger inhibitory activity against drug-resistant variants of the SARS-CoV-2 main protease compared to nirmatrelvir (used in Paxlovid). The research used biochemical, structural, and cellular analyses to show that leritrelvir binding restores the dimerization of protease mutants that have developed resistance to current treatments. The findings suggest leritrelvir could be a more effective treatment option as the virus continues to evolve resistance to existing antivirals.
Researchers evaluated leritrelvir's effectiveness against multiple drug-resistant variants of the SARS-CoV-2 main protease (Mpro), which is a critical target for COVID-19 antiviral development. The study tested the drug against 12 resistance-associated mutations and found that leritrelvir retained stronger inhibitory activity than nirmatrelvir against most resistant mutants. A key mechanism identified was that many resistance mutations cause the protease to dissociate from its dimer form, reducing drug binding; however, leritrelvir's tighter binding restores this dimerization. Sixteen crystal structures revealed how leritrelvir re-establishes critical dimer-interface interactions that resistance mutations had disrupted. Cellular assays confirmed leritrelvir's superior antiviral efficacy, suggesting it could serve as a more durable treatment option as SARS-CoV-2 continues to develop resistance to current therapies.
What's missing
The study does not discuss the clinical availability or regulatory status of leritrelvir outside China, potential limitations in the panel of mutations tested, or how findings might translate to real-world clinical outcomes with circulating variants.
What different sources said
- bioRxivCenter
Enhanced Target Binding by Leritrelvir Restores Dimerization of Mpro Mutants and Mitigates Drug Resistance
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.